Skip to main content
Log in

Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report

  • Original article
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

A 10-year-old girl presented with a cerebral malignant ectomesenchymoma (MEM), a very unusual tumour with undifferentiated mesenchymal as well as ectodermal elements. Somatostatin receptor scintigraphy (SRS) was performed during the diagnostic workup. The recurrent residual tumour mass was exactly visualized with SRS, and was negative after successful treatment of the patient. The potential application of SRS in initial staging, follow-up and therapy planning in MEM is discussed. This is the first application of SRS in MEM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 14 May 1999 Accepted: 8 May 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papós, M., Pekrun, A., Herms, J. et al. Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report. Pediatric Radiology 31, 169–172 (2001). https://doi.org/10.1007/s002470000404

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002470000404

Keywords

Navigation